Allogene Therapeutics
ALLO
ALLO
157 hedge funds and large institutions have $208M invested in Allogene Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 169 → 157 (-12)
31% less capital invested
Capital invested by funds: $301M → $208M (-$93.6M)
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
Holders
157
Holding in Top 10
6
Calls
$223K
Puts
$162K
Top Buyers
| 1 | +$1.41M | |
| 2 | +$1.05M | |
| 3 | +$890K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$492K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$342K |
Top Sellers
| 1 | -$7.24M | |
| 2 | -$4.75M | |
| 3 | -$1.97M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$1.26M |
| 5 |
Jane Street
New York
|
-$796K |
